American Research Group - Trump Approval
Adults
Approve: 30% (=)
Disapprove: 67% (+1)
Trump's lowest net approval in either term
——
Registered voters
Approve: 31% (+1)
Disapprove: 67% (=)
July 16-20 | 1,100 A | 1,004 RV
Winthrop University/YouGov | 6/18-6/23
President Trump approval
❌Disapprove 59%
✅Approve 34%
——
President Trump approval on the issues (net)
❌Immigration: (-9)
❌Foreign policy: (-20)
❌Jobs and the economy: (-26)
❌Conflict with Iran: (-30)
❌Inflation and prices: (-42)
Link to article: https://t.co/DNFl53inYB
Marquette poll | 6/9-6/15
President Trump approval
❌Disapprove 62% (no change)
✅Approve 38% (no change)
(Previous poll | 5/20-5/26)
Link to poll: https://t.co/agvUyayq8R
Drink your coffee black (no additives) if you want the full health benefits.
2-3 cups per day has been associated with a 25% reduction in all-cause mortality. That benefit goes away when cream and/or sugar are added.
I think this happens for a few reasons:
• Dairy proteins can bind to coffee’s antioxidants and polyphenols and slow their absorption.
• Heavy cream, butter, and MCT-heavy coffee don’t necessarily block coffee polyphenols, but they can add substantial saturated fat and calories. For someone watching ApoB or LDL-C, this can work against the very cardiovascular benefits they’re hoping to get from coffee.
a standing ovation for daraxonrasib at asco. over 40k oncologists, entrepreneurs, investors, and patient advocates together celebrating revmed's breakthru in the fight against pancreatic cancer. u never forget these moments. it's what innovation is all about.
This has quietly been a miracle month in medicine.
In the last 5 weeks we’ve got news on:
- retatrutide, the triple agonist GLP-1 from Lilly, basically melting fat and body-wide inflammation at record levels
- RevMed’s new pancreatic cancer drug showing unprecedented abilities to extend life
- small trial of a one-and-done PCSK9 gene editing therapy for slashing LDL cholesterol
- Mayo’s AI-assisted radiology showing vastly improved cancer detection
- this new therapy for metastatic solid tumors
This stuff is at varying levels of evidence. Retatrutide is ~100% on its way, other stuff needs more clinical trial data. But put it together and we’re maybe on the verge of majorly reducing the mortality of heart disease and cancer, the two leading causes of death in America.